To investigate the effect of HTR2A inhibitor on changes of CD8+ T composition in the tumor microenvironment (TME), flow cytometry results showed that HTR2A inhibitor treatment significantly reduced the infiltration of cytotoxic CD8+ T cells in the TME (Figure 8D). This evidence concerns the gene HTR2A and neoplasm.